131
Participants
Start Date
October 31, 2014
Primary Completion Date
October 31, 2020
Study Completion Date
October 31, 2021
Dasatinib
Tom Baker Cancer Center, Calgary
University of Alberta Hospital, Edmonton
Cancer Care Manitoba, Winnipeg
Queen Elizabeth II Health Sciences Centre, Halifax
Juravinski Cancer Centre, Hamilton
London Health Sciences Centre, London
Ottawa General Hospital, Ottawa
Centre Hôpitallier Universitaire de Quebec - Hôpital de l'Enfant-Jésus, Charlesbourg
Hopital Maisonneuve-Rosemont, Montreal
McGill University Health Centre, Montreal
Vancouver General Hospital, Vancouver
Princess Margaret Cancer Centre, Toronto
Collaborators (1)
Ozmosis Research Inc.
INDUSTRY
University Health Network, Toronto
OTHER